40
Participants
Start Date
December 13, 2022
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Lorigerlimab
Given by vein (IV)
RECRUITING
M D Anderson Cancer Center, Houston
Collaborators (1)
MacroGenics
INDUSTRY
M.D. Anderson Cancer Center
OTHER